Accueil>>Signaling Pathways>> Immunology/Inflammation>>N-formyl-2-Aminophenol

N-formyl-2-Aminophenol (Synonyms: 2’-Hydroxyformanilide, NSC 93900)

Catalog No.GC52073

A bacterial secondary metabolite with antioxidant activity

Products are for research use only. Not for human use. We do not sell to patients.

N-formyl-2-Aminophenol Chemical Structure

Cas No.: 2843-27-8

Taille Prix Stock Qté
100 mg
63,00 $US
En stock
250 mg
100,00 $US
En stock
500 mg
156,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

N-formyl-2-Aminophenol is a bacterial secondary metabolite that has been found in P. chrysogenum and has antioxidant activity.1,2 It scavenges DPPH radicals in a cell-free assay with an IC50 value of 3.23 µg/ml.2 N-formyl-2-Aminophenol has also been used in the synthesis of compounds with antibacterial and antifungal activities.3

1.Frisvad, J.C., Smedsgaard, J., Larsen, T.O., et al.Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus PenicilliumStud. Mycol.49201-241(2004) 2.Deepali, A., Akansha, A., Anamika, B., et al.Hydroxylamine hydrochloride as an effective catalyst for form amide derivative synthesis and their DPPH scavenging activityRes. J. Chem. Sci.4(10)54-57(2014) 3.Gupta, S., Verma, P., and Singh, V.Synthesis and antimicrobial study of 2-amino-imidazole derivativesIndian J. Chem. 57B679-686(2018)

Avis

Review for N-formyl-2-Aminophenol

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-formyl-2-Aminophenol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.